• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[(67)Ga]-AMD3100的合成与评估:一种靶向趋化因子受体CXCR4的新型成像剂

Synthesis and Evaluation of [(67)Ga]-AMD3100: A Novel Imaging Agent for Targeting the Chemokine Receptor CXCR4.

作者信息

Aghanejad Ayuob, Jalilian Amir R, Fazaeli Yousef, Alirezapoor Behrouz, Pouladi Mehraban, Beiki Davoud, Maus Stephan, Khalaj Ali

机构信息

Research Center for Nuclear Medicine, Tehran University of Medical Sciences, Tehran, Iran. ; Department of Nuclear Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.

Radiation Application Research School, Nuclear Science and Technology Research Institute, Tehran, 11365-3486, Iran.

出版信息

Sci Pharm. 2013 Sep 12;82(1):29-42. doi: 10.3797/scipharm.1305-18. Print 2014 Jan-Mar.

DOI:10.3797/scipharm.1305-18
PMID:24634840
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3951231/
Abstract

In order to develop a possible C-X-C chemokine receptor type 4 (CXCR4) imaging agent for oncological scintigraphy, [(67)Ga]-labeled 1,1'-[1,4-Phenylene-bis(methylene)]bis(1,4,8,11-tetraazacyclotetradecane) ([(67)Ga]-AMD3100) was prepared by using [(67)Ga]GaCl3 and AMD-3100 for 2 h at 50 °C (radiochemical purity: >95% ITLC, >99% HPLC, specific activity: 1800-2000 TBq/mmol) in acetate buffer. The stability of the complex was checked in the presence of human serum (37 °C) and in the final formulation for four days. The biodistribution of the labeled compound in the vital organs of wild type Sprague-Dawley rats was determined and compared with that of the free Ga(3+) cation up to 48 h. Considering the spleen as the target organ, the best target:non target ratios were obtained 48 h post-injection (spleen:blood ratio; 14.5 and spleen:muscle ratio; 88.4). Initial SPECT images and biodistribution results in the wild type rats matched each other and demonstrated rapid washout of the tracer from the urinary tract. SPECT images in human breast carcinoma-bearing mice demonstrated a detectable tumor uptake in 48 h post-injection.

摘要

为开发一种可能用于肿瘤闪烁显像的C-X-C趋化因子受体4(CXCR4)显像剂,通过在50℃下使用[(67)Ga]GaCl3和AMD-3100在醋酸盐缓冲液中反应2小时制备了[(67)Ga]标记的1,1'-[1,4-亚苯基-双(亚甲基)]双(1,4,8,11-四氮杂环十四烷)([(67)Ga]-AMD3100)(放射化学纯度:ITLC法>95%,HPLC法>99%,比活度:1800 - 2000 TBq/mmol)。在人血清存在下(37℃)以及在最终制剂中检查该配合物的稳定性,为期四天。测定标记化合物在野生型Sprague-Dawley大鼠重要器官中的生物分布,并与游离Ga(3+)阳离子的生物分布进行比较,长达48小时。以脾脏作为靶器官,注射后48小时获得了最佳的靶器官与非靶器官比值(脾脏:血液比值为14.5,脾脏:肌肉比值为88.4)。野生型大鼠的初始SPECT图像和生物分布结果相互匹配,并显示示踪剂从尿路快速清除。荷人乳腺癌小鼠的SPECT图像显示注射后48小时肿瘤有可检测到的摄取。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f42/3951231/36c054956f0b/scipharm.2014.82.29f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f42/3951231/29b2bc593535/scipharm.2014.82.29f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f42/3951231/e093904412fe/scipharm.2014.82.29f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f42/3951231/36c054956f0b/scipharm.2014.82.29f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f42/3951231/29b2bc593535/scipharm.2014.82.29f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f42/3951231/e093904412fe/scipharm.2014.82.29f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f42/3951231/36c054956f0b/scipharm.2014.82.29f4.jpg

相似文献

1
Synthesis and Evaluation of [(67)Ga]-AMD3100: A Novel Imaging Agent for Targeting the Chemokine Receptor CXCR4.[(67)Ga]-AMD3100的合成与评估:一种靶向趋化因子受体CXCR4的新型成像剂
Sci Pharm. 2013 Sep 12;82(1):29-42. doi: 10.3797/scipharm.1305-18. Print 2014 Jan-Mar.
2
Development of a (68)Ga-Fluorinated Porphyrin Complex as a Possible PET Imaging Agent.一种(68)镓-氟化卟啉配合物作为潜在正电子发射断层显像(PET)显像剂的研发
Nucl Med Mol Imaging. 2012 Mar;46(1):20-6. doi: 10.1007/s13139-011-0109-5. Epub 2011 Dec 16.
3
Radiosynthesis and Quality Control of [(67)Ga]-3,4-dimethoxylated Porphyrin Complex as a Possible Imaging agent.[(67)Ga]-3,4-二甲氧基卟啉配合物作为一种潜在显像剂的放射性合成及质量控制
Iran J Pharm Res. 2013 Fall;12(4):735-44.
4
Preparation and Evaluation of (68)Ga-ECC as a PET Renal Imaging Agent.(68)镓-乙氧基亚甲基二膦酸盐作为正电子发射断层显像肾显像剂的制备与评价
Nucl Med Mol Imaging. 2015 Sep;49(3):208-16. doi: 10.1007/s13139-015-0323-7. Epub 2015 Feb 24.
5
[Ga]Ga/[Lu]Lu-BL01, a Novel Theranostic Pair for Targeting C-X-C Chemokine Receptor 4.镓[^68^Ga]/镥[^177^Lu]-BL01,一种新型靶向趋化因子受体 4 的诊疗一体化偶联物。
Mol Pharm. 2019 Nov 4;16(11):4688-4695. doi: 10.1021/acs.molpharmaceut.9b00808. Epub 2019 Oct 4.
6
Preparation and biodistribution studies of a radiogallium-acetylacetonate bis (thiosemicarbazone) complex in tumor-bearing rodents.放射性镓-乙酰丙酮双(硫代半卡巴腙)配合物在荷瘤啮齿动物中的制备及生物分布研究
Iran J Pharm Res. 2012 Spring;11(2):523-31.
7
Development of ga-67 maltolate complex as an imaging agent.没食子酸丙酯-镓67配合物作为一种显像剂的研发。
Iran J Pharm Res. 2012 Summer;11(3):755-62.
8
[⁹⁹mTc]O₂-AMD3100 as a SPECT tracer for CXCR4 receptor imaging.[^99mTc]O₂-AMD3100 作为 CXCR4 受体成像的 SPECT 示踪剂。
Nucl Med Biol. 2013 May;40(4):507-17. doi: 10.1016/j.nucmedbio.2013.02.003. Epub 2013 Mar 20.
9
Evaluation of the Possible Utilization of Ga-DOTATOC in Diagnosis of Adenocarcinoma Breast Cancer.镓-奥曲肽用于乳腺癌诊断的潜在应用评估。
Asia Ocean J Nucl Med Biol. 2018 Winter;6(1):41-49. doi: 10.22038/aojnmb.2017.23695.1168.
10
PET of CXCR4 expression by a (68)Ga-labeled highly specific targeted contrast agent.使用一种(68)Ga 标记的高特异性靶向对比剂进行 CXCR4 表达的 PET。
J Nucl Med. 2011 Nov;52(11):1803-10. doi: 10.2967/jnumed.111.098798.

引用本文的文献

1
Targeting the chemokine receptor CXCR4 for cancer therapies.以趋化因子受体CXCR4为靶点进行癌症治疗。
Biomark Res. 2025 May 1;13(1):68. doi: 10.1186/s40364-025-00778-y.
2
Radionuclide-labelled nanoparticles for cancer combination therapy: a review.放射性核素标记纳米颗粒用于癌症联合治疗:综述。
J Nanobiotechnology. 2024 Nov 22;22(1):728. doi: 10.1186/s12951-024-03020-3.
3
Emerging Nanomedicine Approaches in Targeted Lung Cancer Treatment.新兴纳米医学方法在肺癌靶向治疗中的应用。

本文引用的文献

1
CXCR4-based imaging agents.基于 CXCR4 的成像剂。
J Nucl Med. 2011 Nov;52(11):1665-9. doi: 10.2967/jnumed.111.097733.
2
Evaluation of a fluorescent derivative of AMD3100 and its interaction with the CXCR4 chemokine receptor.评价 AMD3100 的荧光衍生物及其与 CXCR4 趋化因子受体的相互作用。
Chembiochem. 2011 Nov 25;12(17):2692-8. doi: 10.1002/cbic.201100441. Epub 2011 Oct 13.
3
Molecular imaging of CXCR4 receptor expression in human cancer xenografts with [64Cu]AMD3100 positron emission tomography.采用[64Cu]AMD3100 正电子发射断层扫描术对人源异种移植瘤中 CXCR4 受体表达的分子成像。
Int J Mol Sci. 2024 Oct 19;25(20):11235. doi: 10.3390/ijms252011235.
4
CXCR4: From Signaling to Clinical Applications in Neuroendocrine Neoplasms.CXCR4:从信号传导到神经内分泌肿瘤的临床应用
Cancers (Basel). 2024 May 8;16(10):1799. doi: 10.3390/cancers16101799.
5
Theranostics in targeting fibroblast activation protein bearing cells: Progress and challenges.靶向成纤维细胞激活蛋白阳性细胞的治疗学研究:进展与挑战。
Life Sci. 2023 Sep 15;329:121970. doi: 10.1016/j.lfs.2023.121970. Epub 2023 Jul 21.
6
CXCR4-Targeted Radiopharmaceuticals for the Imaging and Therapy of Malignant Tumors.CXCR4 靶向放射性药物在恶性肿瘤的成像和治疗中的应用。
Molecules. 2023 Jun 12;28(12):4707. doi: 10.3390/molecules28124707.
7
Recent Trends in Diagnostic Biomarkers of Tumor Microenvironment.肿瘤微环境诊断生物标志物的最新研究进展
Mol Imaging Biol. 2023 Jun;25(3):464-482. doi: 10.1007/s11307-022-01795-1. Epub 2022 Dec 14.
8
Clinical Evaluation of Nuclear Imaging Agents in Breast Cancer.乳腺癌核医学显像剂的临床评估
Cancers (Basel). 2022 Apr 23;14(9):2103. doi: 10.3390/cancers14092103.
9
At the Bench: Pre-clinical evidence for multiple functions of CXCR4 in cancer.在实验台上:CXCR4 在癌症中的多种功能的临床前证据。
J Leukoc Biol. 2021 May;109(5):969-989. doi: 10.1002/JLB.2BT1018-715RR. Epub 2020 Oct 26.
10
Imaging CXCR4 Expression with Iodinated and Brominated Cyclam Derivatives.用碘代和溴代环脒衍生物进行 CXCR4 表达的成像。
Mol Imaging Biol. 2020 Oct;22(5):1184-1196. doi: 10.1007/s11307-020-01480-1.
Cancer Res. 2010 May 15;70(10):3935-44. doi: 10.1158/0008-5472.CAN-09-4396. Epub 2010 May 11.
4
Immunoimaging of CXCR4 expression in brain tumor xenografts using SPECT/CT.使用单光子发射计算机断层扫描/计算机断层扫描(SPECT/CT)对脑肿瘤异种移植模型中CXCR4表达进行免疫成像。
J Nucl Med. 2009 Jul;50(7):1124-30. doi: 10.2967/jnumed.108.061325. Epub 2009 Jun 12.
5
64Cu-AMD3100--a novel imaging agent for targeting chemokine receptor CXCR4.64Cu-AMD3100——一种用于靶向趋化因子受体CXCR4的新型成像剂。
Bioorg Med Chem. 2009 Feb 15;17(4):1486-93. doi: 10.1016/j.bmc.2009.01.014. Epub 2009 Jan 15.
6
Silencing of CXCR4 blocks breast cancer metastasis.沉默CXCR4可阻断乳腺癌转移。
Cancer Res. 2005 Feb 1;65(3):967-71.
7
CXCR4 regulates growth of both primary and metastatic breast cancer.CXCR4调节原发性和转移性乳腺癌的生长。
Cancer Res. 2004 Dec 1;64(23):8604-12. doi: 10.1158/0008-5472.CAN-04-1844.
8
Cancer and the chemokine network.癌症与趋化因子网络
Nat Rev Cancer. 2004 Jul;4(7):540-50. doi: 10.1038/nrc1388.
9
Metal ion enhanced binding of AMD3100 to Asp262 in the CXCR4 receptor.金属离子增强AMD3100与CXCR4受体中Asp262的结合。
Biochemistry. 2003 Jan 28;42(3):710-7. doi: 10.1021/bi0264770.
10
A novel anti-HIV synthetic peptide, T-22 ([Tyr5,12,Lys7]-polyphemusin II).一种新型抗HIV合成肽,T-22([酪氨酸5,12,赖氨酸7] - 多聚半胱氨酸II)
Biochem Biophys Res Commun. 1992 Dec 15;189(2):845-50. doi: 10.1016/0006-291x(92)92280-b.